Demand far outstrips the supply of N95 respirators
Due to global shortages, 3M Co has ramped up its production of N95 respirators, doubling its normal output. The company is currently manufacturing 100 million N95 respirators per month worldwide, with 35 million of these being produced in the US. Furthermore, 3M Chief Executive Officer Mike Roman has stated that the company aims to increase its US production of N95 respirators even further, to reach 50 million per month by June 2020.
Keystone Heart Ltd pushes forward with CE approval for cerebral embolic protection device
Amidst the ongoing Covid-19 pandemic, Keystone Heart Ltd secured CE approval for its cerebral embolic protection device, the TriGUARD3. However, GlobalData expects that the company will experience a rocky start as a result of the pandemic.
Chronic wound patients susceptible to Covid-19 but cannot access key prevention services
Patients suffering from chronic wounds are in a uniquely dangerous situation as the Covid-19 crisis continues.
According to the American College of Tissue and Wound Repair, widespread new policies aimed at diverting resources to coronavirus treatment have led to hospitals shutting down outpatient resources that help chronic wound patients manage their conditions. With no access to training or professional monitoring, patients are at risk of developing complications that require emergency medicine, furthering their risk of viral exposure.